Mode
Text Size
Log in / Sign up

pantoprazole

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of pantoprazole

25 trials tracked of pantoprazole: 12 in phase 3 or 4 and 3 with published results. The most-cited published study has 2421 citations.

25Trials tracked
12Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 6 Phase 3 6 Phase 2 4 Phase 1 3 Other / NA 6
  1. Phase 3 Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease Completed · 2,421 cited
  2. Phase 4 Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients Completed · 78 cited
  3. Phase 4 Stress Ulcer Prophylaxis in the Intensive Care Unit Completed · 33 cited
  4. Phase 4 Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS Completed
  5. Phase 4 Comparison of Pantoprazole and Ranitidine in Dyspepsia Completed
  6. Phase 4 A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation Completed
Show 19 more trials
  1. Phase 4 Symptomatic Relief of Acute Dyspeptic Pain in Emergency Department With Pantoprazole Completed
  2. Phase 3 Aspirin in Young Psychotic Patients Completed
  3. Phase 3 Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD) Completed
  4. Phase 3 Pantoprazole on Insulin Secretion in Diabetes Completed
  5. Phase 3 Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD) Completed
  6. Phase 3 Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD Completed
  7. Phase 2 Incretin Effect and Use After Clinical Islet Transplantation Completed
  8. Phase 2 Histamine Glutamate Antagonism in Stroke Completed
  9. Phase 2 Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy Completed
  10. Phase 2 Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor Completed
  11. Phase 1 Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis Subjects Completed
  12. Phase 1 Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot Study Completed
  13. Phase 1 PK Study With Pantoprazole in Obese Children and Adolescents Completed
  14. N/A Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders Completed
  15. N/A Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea Completed
  16. N/A Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease Completed
  17. N/A Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS) Completed
  18. N/A Structured Non-operative Treatment of Knee Osteoarthritis Completed
  19. N/A Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD) Completed

Showing the 25 most-cited and recently-updated of 25 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.